In focus · trending topic

JAMA Neurology

1 stories · following the connections

Adamas Announces Publication of ADS-5102 Phase 3 EASE LID Clinical Trial in JAMA Neurology

By Nasdaq OMXJun 12, 2017, 8:01 PM UTC